Literature DB >> 19141643

Transcriptional repression of epithelial cell adhesion molecule contributes to p53 control of breast cancer invasion.

Narendra V Sankpal1, Michael W Willman, Timothy P Fleming, John D Mayfield, William E Gillanders.   

Abstract

p53 is a tumor suppressor gene with well-characterized roles in cell cycle regulation, apoptosis, and maintenance of genome stability. Recent evidence suggests that p53 may also contribute to the regulation of migration and invasion. Epithelial cell adhesion molecule (EpCAM) is a transmembrane glycoprotein that is overexpressed in the majority of human epithelial carcinomas, including breast and colorectal carcinomas. We show by chromatin immunoprecipitation assays that p53 interacts with a candidate p53 binding site within the EpCAM gene. p53-mediated transcriptional repression of EpCAM was confirmed in gain-of-function and loss-of-function experimental systems. Induction of wild-type p53 was associated with a significant dose-dependent decrease in EpCAM expression; conversely, specific ablation of p53 was associated with a significant increase in EpCAM expression. At the functional level, specific ablation of p53 expression is associated with increased breast cancer invasion, and this effect is abrogated by concomitant specific ablation of EpCAM expression. Taken together, these biochemical and functional data are the first demonstration that (a) wild-type p53 protein binds to a response element within the EpCAM gene and negatively regulates EpCAM expression, and (b) transcriptional repression of EpCAM contributes to p53 control of breast cancer invasion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19141643      PMCID: PMC3907266          DOI: 10.1158/0008-5472.CAN-08-2708

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  20 in total

1.  Surfing the p53 network.

Authors:  B Vogelstein; D Lane; A J Levine
Journal:  Nature       Date:  2000-11-16       Impact factor: 49.962

Review 2.  Transcriptional repression mediated by the p53 tumour suppressor.

Authors:  J Ho; S Benchimol
Journal:  Cell Death Differ       Date:  2003-04       Impact factor: 15.828

3.  The p53MH algorithm and its application in detecting p53-responsive genes.

Authors:  J Hoh; S Jin; T Parrado; J Edington; A J Levine; J Ott
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-19       Impact factor: 11.205

4.  Global transcriptional program of p53 target genes during the process of apoptosis and cell cycle progression.

Authors:  Asra Mirza; Qun Wu; Luquan Wang; Terri McClanahan; W Robert Bishop; Ferdous Gheyas; Wei Ding; Beth Hutchins; Tish Hockenberry; Paul Kirschmeier; Jonathan R Greene; Suxing Liu
Journal:  Oncogene       Date:  2003-06-05       Impact factor: 9.867

5.  p19Arf-p53 tumor suppressor pathway regulates cell motility by suppression of phosphoinositide 3-kinase and Rac1 GTPase activities.

Authors:  Fukun Guo; Yuan Gao; Lei Wang; Yi Zheng
Journal:  J Biol Chem       Date:  2003-02-10       Impact factor: 5.157

6.  Expression of Ep-CAM shifts the state of cadherin-mediated adhesions from strong to weak.

Authors:  Manon J Winter; Bas Nagelkerken; Alexander E E Mertens; Hellen A M Rees-Bakker; Inge H Briaire-de Bruijn; Sergey V Litvinov
Journal:  Exp Cell Res       Date:  2003-04-15       Impact factor: 3.905

7.  Mutations of TP53 induce loss of DNA methylation and amplification of the TROP1 gene.

Authors:  Ashraf F Nasr; Michele Nutini; Barbara Palombo; Emanuela Guerra; Savenio Alberti
Journal:  Oncogene       Date:  2003-03-20       Impact factor: 9.867

Review 8.  EpCAM: A new therapeutic target for an old cancer antigen.

Authors:  Andrew Armstrong; Stephen L Eck
Journal:  Cancer Biol Ther       Date:  2003 Jul-Aug       Impact factor: 4.742

9.  Prognostic effect of epithelial cell adhesion molecule overexpression in untreated node-negative breast cancer.

Authors:  Marcus Schmidt; Dirk Hasenclever; Mitra Schaeffer; Daniel Boehm; Cristina Cotarelo; Eric Steiner; Antje Lebrecht; Wulf Siggelkow; Wolfgang Weikel; Ilka Schiffer-Petry; Susanne Gebhard; Henryk Pilch; Mathias Gehrmann; Hans-Anton Lehr; Heinz Koelbl; Jan G Hengstler; Martin Schuler
Journal:  Clin Cancer Res       Date:  2008-09-15       Impact factor: 12.531

10.  Frequent EpCam protein expression in human carcinomas.

Authors:  Philip Th Went; Alessandro Lugli; Sandra Meier; Marcel Bundi; Martina Mirlacher; Guido Sauter; Stephan Dirnhofer
Journal:  Hum Pathol       Date:  2004-01       Impact factor: 3.466

View more
  48 in total

Review 1.  Expression kinetics of hepatic progenitor markers in cellular models of human liver development recapitulating hepatocyte and biliary cell fate commitment.

Authors:  Pooja Chaudhari; Lipeng Tian; Abhijeet Deshmukh; Yoon-Young Jang
Journal:  Exp Biol Med (Maywood)       Date:  2016-07-06

2.  A double-negative feedback loop between EpCAM and ERK contributes to the regulation of epithelial-mesenchymal transition in cancer.

Authors:  N V Sankpal; T P Fleming; P K Sharma; H J Wiedner; W E Gillanders
Journal:  Oncogene       Date:  2017-02-13       Impact factor: 9.867

3.  Rad is a p53 direct transcriptional target that inhibits cell migration and is frequently silenced in lung carcinoma cells.

Authors:  Bo-Yuan Hsiao; Chun-Chin Chen; Pei-Chen Hsieh; Tsun-Kai Chang; Yi-Chen Yeh; Yu-Chung Wu; Han-Shui Hsu; Fung-Fang Wang; Teh-Ying Chou
Journal:  J Mol Med (Berl)       Date:  2011-01-11       Impact factor: 4.599

4.  Cleavage and cell adhesion properties of human epithelial cell adhesion molecule (HEPCAM).

Authors:  Thanos Tsaktanis; Heidi Kremling; Miha Pavšič; Ricarda von Stackelberg; Brigitte Mack; Akio Fukumori; Harald Steiner; Franziska Vielmuth; Volker Spindler; Zhe Huang; Jasmine Jakubowski; Nikolas H Stoecklein; Elke Luxenburger; Kirsten Lauber; Brigita Lenarčič; Olivier Gires
Journal:  J Biol Chem       Date:  2015-08-19       Impact factor: 5.157

5.  Effects of low-density lipoprotein docosahexaenoic acid nanoparticles on cancer stem cells isolated from human hepatoma cell lines.

Authors:  J Yang; Y Gong; D P Sontag; I Corbin; G Y Minuk
Journal:  Mol Biol Rep       Date:  2018-08-01       Impact factor: 2.316

Review 6.  Emerging roles of aerobic glycolysis in breast cancer.

Authors:  Z Wu; J Wu; Q Zhao; S Fu; J Jin
Journal:  Clin Transl Oncol       Date:  2019-07-29       Impact factor: 3.405

7.  MMP7 is a target of the tumour-associated antigen EpCAM.

Authors:  Sabine Denzel; Brigitte Mack; Carola Eggert; Petra Massoner; Nikolas Stöcklein; Dirk Kemming; Ulrich Harréus; Olivier Gires
Journal:  Int J Exp Pathol       Date:  2012-10       Impact factor: 1.925

8.  Epithelial cell adhesion molecule (EpCAM) is overexpressed in breast cancer metastases.

Authors:  Ashley Cimino; Marc Halushka; Peter Illei; Xinyan Wu; Saraswati Sukumar; Pedram Argani
Journal:  Breast Cancer Res Treat       Date:  2009-12-11       Impact factor: 4.872

Review 9.  Pancreatic cancer stem cell markers and exosomes - the incentive push.

Authors:  Sarah Heiler; Zhe Wang; Margot Zöller
Journal:  World J Gastroenterol       Date:  2016-07-14       Impact factor: 5.742

10.  EpCAM modulates NF-κB signaling and interleukin-8 expression in breast cancer.

Authors:  Narendra V Sankpal; Timothy P Fleming; William E Gillanders
Journal:  Mol Cancer Res       Date:  2013-02-01       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.